Cargando…

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women

The levonorgestrel-releasing intrauterine system (LNG-IUS) is a highly effective contraceptive method that has several noncontraceptive benefits. It has been used in various gynecological conditions, such as heavy menstrual bleeding, dysmenorrhea, and endometrial hyperplasia. During the perimenopaus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joo, Jong-Kil, Shin, Jung-Ho, Lee, Jung Ryeol, Kim, Mee-Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Menopause 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408317/ https://www.ncbi.nlm.nih.gov/pubmed/34463068 http://dx.doi.org/10.6118/jmm.20038

Ejemplares similares

Efficacy of levonorgestrel releasing intrauterine system for the treatment of menorrhagia due to benign uterine lesions in perimenopausal women
por: Desai, Rathnamala M.
Publicado: (2012)

Effect of myoma size on failure of thermal balloon ablation or levonorgestrel releasing intrauterine system treatment in women with menorrhagia
por: Kim, Ju Yeong, et al.
Publicado: (2013)

Effectiveness of Levonorgestrel Releasing Intrauterine System in Perimenopausal Women with Heavy Menstrual Bleeding: A Prospective Study at a Teaching Hospital in India
por: Nidhi,, et al.
Publicado: (2022)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
por: Choi, Sangwon, et al.
Publicado: (2021)

Long-term efficacy and safety of levonorgestrel-releasing intrauterine system as a maintenance treatment for endometriosis
por: Kim, Hye Yun, et al.
Publicado: (2022)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
por: Gunardi, Eka Rusdianto, et al.
Publicado: (2022)

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
por: Beatty, Megan N, et al.
Publicado: (2009)

Are women satisfied when using levonorgestrel-releasing intrauterine system for treatment of abnormal uterine bleeding?
por: Mansukhani, Nina, et al.
Publicado: (2013)

Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
por: Kailasam, Chandra, et al.
Publicado: (2008)

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review
por: Zgliczynska, Magdalena, et al.
Publicado: (2020)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners
por: Nanda, Geeta, et al.
Publicado: (2018)

Retracted: Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
por: Lang, Benjamin, et al.
Publicado: (2018)

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
por: Zhang, Peihai, et al.
Publicado: (2013)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia
por: Gök, Soner, et al.
Publicado: (2022)

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
por: Roman, Jose D
Publicado: (2022)

Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users
por: Spotnitz, Matthew E., et al.
Publicado: (2020)

Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system
por: Steshenko, Alexander, et al.
Publicado: (2021)

Effect of modified levonorgestrel‐releasing intrauterine system in human adenomyosis with heavy menstrual bleeding
por: Yang, Hong, et al.
Publicado: (2021)

An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
por: Zhang, Huizhi, et al.
Publicado: (2022)

Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review
por: Zürcher, Aline, et al.
Publicado: (2022)

Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training
por: Huang, JinCheng, et al.
Publicado: (2023)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use
por: Miranda, Laura, et al.
Publicado: (2021)

Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey
por: Zhao, Shuping, et al.
Publicado: (2014)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
por: Behnamfar, Fariba, et al.
Publicado: (2014)

Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System—A Review of 10 Years of Clinical Experience
por: Wildemeersch, Dirk, et al.
Publicado: (2016)

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling
por: Costescu, Dustin J
Publicado: (2016)

Peritoneal inclusion cysts treated with a levonorgestrel-releasing intrauterine system: A case report
por: Tamai, Hanako, et al.
Publicado: (2019)

Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis
por: Cai, Yuru, et al.
Publicado: (2023)

Effects of the levonorgestrel‐releasing intrauterine device on the immune microenvironment of the human cervix and endometrium
por: Shanmugasundaram, Uma, et al.
Publicado: (2016)

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
por: de Oliveira, Elaine Cristina Fontes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gc1isdclvoglokiunb9nucubrg